CYT
Click for more information
0.00% 13.0¢ cytopia limited

acquisition

  1. ronnie12
    37 Posts.
    clock Created with Sketch.
    10/08/09
    11:22
    Post #: 5487532
    I understand CXS doing early due diligence on CYT as CXS exhibits greater conficence of upcoming successful IND approval in US for omacetaxine. Clearly CXS looking to access additional local well advanced oncology drug development programs and exhibiting confidence its own management to repeat what others have struggled to do themselves in this country. Will be watching closely.
    CYT Price at posting: 8.0¢ Sentiment: None Disclosure: Not Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

BOT US FDA approves Botanix Pharma's excessive underarm sweat drug
right-arrow Created with Sketch.
GWR Scoping study and Phase 2 drilling progress Prospect Ridge magnesium play for GWR
right-arrow Created with Sketch.
NEWS Microcap Madness: 5 junior explorers with news out on Thursday 20 June
right-arrow Created with Sketch.
WAF West African Resources draws final US$100M from Sprott-backed loan for gold plant
right-arrow Created with Sketch.
RDN If you thought lithium was dead, think again. The Pilbara will be central to the next upswing
right-arrow Created with Sketch.
TLG Talga to form joint venture with lithium producer SQM to develop Sweden's Aero project
right-arrow Created with Sketch.
watchlist Created with Sketch. Add CYT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.